|
USP1 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.575880E-03 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.599600E-02 |
| Normal-vs-Stage2 |
2.260200E-01 |
| Normal-vs-Stage3 |
1.351850E-04 |
| Normal-vs-Stage4 |
4.247000E-04 |
| Stage1-vs-Stage2 |
9.218600E-01 |
| Stage1-vs-Stage3 |
1.521800E-02 |
| Stage1-vs-Stage4 |
3.551700E-02 |
| Stage2-vs-Stage3 |
2.502800E-01 |
| Stage2-vs-Stage4 |
3.185400E-01 |
| Stage3-vs-Stage4 |
8.182000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.416400E-03 |
| Normal-vs-AfricanAmerican |
1.567930E-04 |
| Normal-vs-Asian |
6.952200E-01 |
| Caucasian-vs-AfricanAmerican |
6.337700E-02 |
| Caucasian-vs-Asian |
5.861400E-01 |
| AfricanAmerican-vs-Asian |
1.668770E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.216100E-04 |
| Normal-vs-Female |
3.451500E-02 |
| Male-vs-Female |
2.026400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.270600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.374350E-02 |
| Normal-vs-Age(61-80Yrs) |
1.676050E-03 |
| Normal-vs-Age(81-100Yrs) |
4.195600E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.586000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
7.003200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.292800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.388000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.670170E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.684200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
9.734800E-01 |
| Normal-vs-Grade 2 |
3.758200E-01 |
| Normal-vs-Grade 3 |
2.5790000002246E-07 |
| Normal-vs-Grade 4 |
2.010100E-04 |
| Grade 1-vs-Grade 2 |
7.544200E-01 |
| Grade 1-vs-Grade 3 |
1.205570E-02 |
| Grade 1-vs-Grade 4 |
4.943600E-02 |
| Grade 2-vs-Grade 3 |
3.50549999994509E-06 |
| Grade 2-vs-Grade 4 |
1.160210E-03 |
| Grade 3-vs-Grade 4 |
9.214800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
5.664400E-01 |
| Normal-vs-ccB subtype |
3.197100E-04 |
| ccA subtype-vs-ccB subtype |
2.590300E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.162300E-03 |
| Normal-vs-N1 |
8.871500E-02 |
| N0-vs-N1 |
7.960600E-01 |
|
|
